Are VOGDAY TRIO 1 TABLET and VOGLY GM1 SR the same?

Yes, VOGDAY TRIO 1 TABLET and VOGLY GM1 SR contain the same active salt (GLIMEPIRIDE 1MG + METFORMIN 500MG + VOGLIBOSE 0.2MG) in the same strength and provide identical therapeutic efficacy, meeting strict quality and safety standards.

Save 59%

Hover to zoom

WHO/GMP CERTIFIED

FAST DELIVERY

SAFE & SECURE PAYMENT

7 DAYS EASY RETURN

Diabetes Care

VOGDAY TRIO 1 TABLET

Name: VOGDAY TRIO 1 TABLET
Brand: Medingen
SKU: 46255
Price: 53.00 INR
Availability: InStock

Composition:GLIMEPIRIDE 1MGMETFORMIN 500MGVOGLIBOSE 0.2MG10's

₹53₹130Saving: ₹77.00

Inclusive of all taxes

Know Your Delivery Date

Enter pincode to check estimated delivery

Substitutes of VOGDAY TRIO 1 TABLET

SOLD OUT

75% OFF

VOGLY GM1 SR

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹35.00₹80.00

74% OFF

GLIMIHEM MV1

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹37.00

71% OFF

GLIMIHELP VM1/0.2

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹41.00

66% OFF

VOGLIOS GM 1

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹48.00₹70.80

64% OFF

VOKEM GM1

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹57.00₹96.70

48% OFF

GLIMDA MV 1

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹127.22

VOGDAY TRIO 1 TABLET tablet contains glimepiride + metformin + voglibose, a triple-combination oral anti-diabetic medicine used in adults with type 2 diabetes mellitus when diet, exercise, and dual-drug therapy do not provide adequate control. It combines a sulfonylurea, a biguanide, and an alpha-glucosidase inhibitor to provide three-way glucose control—one helps the pancreas release more insulin, another reduces glucose production in the liver and improves insulin sensitivity, while the third slows carbohydrate absorption from the intestine to reduce post-meal sugar spikes. VOGDAY TRIO 1 TABLET tablet is commonly available in strengths such as 1 mg/500 mg/0.2 mg and 1 mg/500 mg/0.3 mg SR, with the VOGDAY TRIO 1 TABLET dosage adjusted according to HbA1c, fasting glucose, meal-time sugar spikes, and kidney function.

Pharmacist Note

Take VOGDAY TRIO 1 TABLET tablet with the first main meal of the day to reduce stomach upset and improve post-meal sugar control. Do not skip meals after taking it, because the chance of low blood sugar increases. Keep glucose tablets, sugar candy, or fruit juice nearby in case you develop sweating, tremors, sudden hunger, or weakness.

Advanced Type 2 Diabetes Control

VOGDAY TRIO 1 TABLET tablet helps control blood sugar in adults whose diabetes is not adequately managed with one or two medicines alone. Better sugar control supports improved HbA1c and lowers the long-term risk of diabetic kidney disease, nerve damage, and eye complications.

Controls Post-meal Sugar Spikes

VOGDAY TRIO 1 TABLET tablet is especially useful for reducing sharp blood sugar rises after meals. By slowing carbohydrate breakdown in the gut, it helps maintain steadier glucose levels through the day.

Triple Mechanism Action

VOGDAY TRIO 1 TABLET tablet works through three complementary pathways for stronger glucose control. It boosts insulin release, reduces liver glucose output, and slows intestinal glucose absorption, making it effective for both fasting and post-meal sugars.

Convenient Fixed-dose Therapy

By combining three anti-diabetic medicines into one tablet, VOGDAY TRIO 1 TABLET tablet reduces pill burden and improves convenience. This may improve adherence in patients who need long-term diabetes management.

While generally safe and well-tolerated, high doses or sensitivity can cause some side effects.

Type

Symptoms

Severity

Common

Nausea, abdominal pain, constipation, bloating, hypoglycemia

Common

Moderate

Diarrhea, flatulence, dizziness, headache, altered taste

Occasional

Serious

Severe hypoglycemia, lactic acidosis, liver injury, allergic... show more

Rare

Dosage

The VOGDAY TRIO 1 TABLET dosage is individualized based on fasting sugar, post-m... show more

Timing

Take VOGDAY TRIO 1 TABLET tablet with breakfast or the first major meal of the d... show more

Limit

Do not exceed the prescribed VOGDAY TRIO 1 TABLET dosage, even if blood sugar is... show more

Consistency

Take VOGDAY TRIO 1 TABLET tablet at the same time every day for steady glucose c... show more

VOGDAY TRIO 1 TABLET tablet works through three glucose-lowering actions. One component stimulates the pancreas to release insulin, another lowers liver glucose production and improves insulin sensitivity, while the third slows the breakdown of complex carbohydrates in the intestine to reduce post-meal sugar spikes. This combined effect helps control both fasting and after-meal glucose levels and supports better long-term HbA1c control.

Pregnancy

VOGDAY TRIO 1 TABLET tablet should only be used during pregnancy if specifically prescribed by a doctor. Insulin is often preferred for tighter and safer blood sugar control in pregnancy.

Alcohol

Avoid alcohol while taking VOGDAY TRIO 1 TABLET tablet because it can increase the risk of low blood sugar and metformin-related lactic acidosis. Even occasional intake should be discussed with your doctor.

Driving

VOGDAY TRIO 1 TABLET tablet may cause sweating, dizziness, blurred vision, or shakiness if blood sugar drops too low. Check glucose before driving and avoid long trips if symptoms occur.

Kidney

Patients with kidney disease may need careful dose adjustment because the metformin component can accumulate and increase side effects. Regular renal function monitoring is important.

Elderly

Older adults may be more sensitive to VOGDAY TRIO 1 TABLET side effects such as hypoglycemia and constipation. Lower starting doses and closer monitoring are often recommended.

Children

VOGDAY TRIO 1 TABLET tablet is generally not routinely recommended in children unless prescribed by a specialist. Safety and dosing depend on age, body weight, and diabetes severity.

Insulin (Antidiabetic)

May significantly increase the glucose-lowering effect of VOGDAY TRIO 1 TABLET tablet and raise severe hypoglycemia risk.

High

Fluconazole (Antifungal)

May increase glimepiride levels and prolong the action of VOGDAY TRIO 1 TABLET tablet, increasing low sugar episodes.

High

Prednisolone (Steroid)

May reduce the sugar-lowering effect of VOGDAY TRIO 1 TABLET tablet and worsen glucose control.

Moderate

Acarbose (Alpha-glucosidase inhibitor)

May increase gastrointestinal side effects when used with VOGDAY TRIO 1 TABLET tablet.

Moderate

What are the main VOGDAY TRIO 1 TABLET tablet uses?

The main VOGDAY TRIO 1 TABLET tablet uses include controlling type 2 diabetes when dual therapy is not enough, especially in patients with high post-meal sugar spikes. It is useful for both fasting and after-meal glucose control.

Can VOGDAY TRIO 1 TABLET tablet cause low blood sugar?

Yes, one of the important VOGDAY TRIO 1 TABLET side effects is hypoglycemia, especially if meals are skipped, delayed, or after heavy exercise. Always keep a quick sugar source with you and monitor blood glucose regularly.

Can VOGDAY TRIO 1 TABLET tablet cause gas or bloating?

Yes, bloating, flatulence, constipation, and abdominal discomfort are known VOGDAY TRIO 1 TABLET side effects due to the voglibose and metformin components. Taking it with food and following the prescribed VOGDAY TRIO 1 TABLET dosage usually improves tolerance.

What should I do if I miss a dose of VOGDAY TRIO 1 TABLET tablet?

Take the missed dose with food as soon as you remember on the same day. If it is close to the next VOGDAY TRIO 1 TABLET dosage time, skip the missed dose and continue normally without doubling.

How long should I continue VOGDAY TRIO 1 TABLET tablet uses?

VOGDAY TRIO 1 TABLET tablet uses are usually long-term because type 2 diabetes needs continuous management. Your doctor may continue or adjust treatment depending on HbA1c, post-meal sugar trends, and kidney function.

Tata 1mg – https://www.1mg.com/generics/glimepiride-metformin-voglibose-401795
Apollo Pharmacy – https://www.apollopharmacy.in/salt/GLIMEPIRIDE%2BMETFORMIN%2BVOGLIBOSE
NICE – https://www.nice.org.uk/guidance/ng28
Mayo Clinic – https://www.mayoclinic.org/diseases-conditions/type-2-diabetes
ADA – https://diabetes.org/diabetes/medication-management

Disclaimer

: The information provided on this page is for informational and educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.

WRITTEN BY

Dr. Helan, PharmD

REVIEWED BY

Dr. Lakshmi MBBS, MD

LAST UPDATED

Oct 12, 2024